Addus HomeCare Corporation (NASDAQ:ADUS) Receives $136.90 Consensus Price Target from Analysts

Addus HomeCare Corporation (NASDAQ:ADUS) has been assigned an average rating of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $136.90.

ADUS has been the subject of several analyst reports. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Barclays boosted their price target on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. BMO Capital Markets initiated coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective on the stock. TD Cowen boosted their target price on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Finally, Cowen reiterated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th.

Addus HomeCare Trading Down 1.6%

Shares of NASDAQ ADUS opened at $109.65 on Friday. The business has a 50 day simple moving average of $112.91 and a 200 day simple moving average of $113.35. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $136.72. The stock has a market cap of $2.03 billion, a price-to-earnings ratio of 23.48, a PEG ratio of 1.34 and a beta of 0.92. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.53 by $0.03. The firm had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The company’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.30 earnings per share. On average, research analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Darby Anderson sold 20,000 shares of Addus HomeCare stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the transaction, the executive vice president owned 44,144 shares in the company, valued at $4,811,696. This trade represents a 31.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In the last quarter, insiders have sold 20,316 shares of company stock valued at $2,215,998. Company insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently made changes to their positions in the business. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. AlphaQuest LLC bought a new position in Addus HomeCare in the 3rd quarter worth approximately $37,000. Wexford Capital LP acquired a new position in shares of Addus HomeCare during the third quarter worth approximately $41,000. State of Wyoming bought a new stake in shares of Addus HomeCare in the second quarter valued at approximately $47,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Addus HomeCare in the second quarter worth $61,000. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.